Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
carnitine + methylsilanol mannuronate + cynara scolymus leaf extract + melilotus officinalis extract + hydrogenated lecithin + caffeine + troxerutin + tyrosine
- Development stage
- Unknown
- Lead developer
- Institute BCN
- Modality
- Small Molecules
- Administration
- Subcutaneous, Intradermal, Topical
01
Overview
This multi-ingredient formulation is a mesotherapy cocktail designed for aesthetic medicine, specifically targeting localized fat deposits, cellulite, and skin laxity. The combination leverages several mechanisms: **L-carnitine** facilitates the transport of long-chain fatty acids into mitochondria for beta-oxidation; **caffeine** acts as a phosphodiesterase inhibitor to increase intracellular cAMP and stimulate lipolysis; **methylsilanol mannuronate** (organic silica) provides structural support to the connective tissue and promotes lipolysis; **Cynara scolymus** (artichoke) extract serves as a diuretic and choleretic agent to aid lymphatic drainage; **Melilotus officinalis** (sweet clover) and **troxerutin** improve microcirculation and reduce capillary permeability; and **tyrosine** serves as a metabolic precursor. The product is typically administered via micro-injections into the subcutaneous tissue to improve body contouring and skin texture.
- Brand names
- BCN Lipid-Peptides
- Other names
- BCN Lipid-Peptides Cocktail
02
Targets
ADORA2A (Adenosine A₂A Receptor)SLC7A1 (Cationic amino acid transporter 1)PDE (Phosphodiesterase family)ADORA1 (Adenosine receptor A1 subtype)
Beyond the preview
Go deeper on carnitine + methylsilanol mannuronate + cynara scolymus leaf extract + melilotus officinalis extract + hydrogenated lecithin + caffeine + troxerutin + tyrosine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on carnitine + methylsilanol mannuronate + cynara scolymus leaf extract + melilotus officinalis extract + hydrogenated lecithin + caffeine + troxerutin + tyrosine.